Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

NCT05916105 | Completed

• 1 other identifier: Ciprofloxacin Utilization
• Study Type: observational
• Target: 151
• Locations: 1 country
• Sites: 1

Brief Summary

Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use. Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.

Conditions

Ciprofloxacin Adverse Reaction

Keywords

Ciprofloxacin; Use evaluation; Drug interaction

Outcome Measures

Primary Outcomes (3)

• Indications

  Appropriate Indications of ciprofloxacin (frequency )

  6 months

• ciprofloxacin prescription (frequency )

  Number of appropriate ciprofloxacin prescription

  6 months

• adverse events

  adverse events occured during ciprofloxacin therapy (frequency )

  6 months

Study Arms (1)

Ciprofloxacin

151 record of Ciprofloxacin

Drug: Ciprofloxacin Tablets

Interventions

Ciprofloxacin Tablets DRUG

Ciprofloxacin antibiotic

Also known as: Ciprofloxacin

Ciprofloxacin

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

A total of 151 patients' record indicated for ciprofloxacin were included in the study.

You may qualify if:

• All ciprofloxacin included prescription during the study period.

You may not qualify if:

• un included ciprofloxacin prescription.

Sponsors & Collaborators

• Damanhour University: lead

Study Sites (1)

Rehab Hussein Werida

Damanhūr, Elbehairah, 31527, Egypt

Location

Related Publications (2)

• Goldman MP. Ciprofloxacin drug utilization review and prospective drug use evaluation. DICP. 1990 Jan;24(1):82-6. doi: 10.1177/106002809002400115.

  PMID: 2301191 BACKGROUND

• Davis R, Markham A, Balfour JA. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.

  PMID: 8736621 BACKGROUND

MeSH Terms

Interventions

Ciprofloxacin

Intervention Hierarchy (Ancestors)

Fluoroquinolones; 4-Quinolones; Quinolones; Quinolines; Heterocyclic Compounds, 2-Ring; Heterocyclic Compounds, Fused-Ring; Heterocyclic Compounds

Study Officials

• Rehab H Werida, Ass. Prof.

  Damanhour University

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 13, 2023
• First Posted: June 23, 2023
• Study Start: September 1, 2021
• Primary Completion: February 28, 2022
• Study Completion: March 1, 2022
• Last Updated: June 23, 2023

Record last verified: 2023-06

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)